Clinical Trials

Join a clinical trial with us and access new treatments today.

Register for more information and find out how you could not only make a difference in the future of healthcare discovery, but benefit from our state-of-the-art assessments,

Call Now: 0800 802 1030

"*" indicates required fields

Step 1 of 3

Submit your interest to our team of specialists

First Name*

Last Name*

Email*

Phone Number*

Explore the page

What to Expect
About Our Trials
Types of Trials
Benefits
Our Clinics

Alzheimer's: A Turning Point?

Re:Cognition Health has recently been featured on BBC One’s Panorama, “Alzheimer’s: A Turning Point?”. This follows the journey of volunteers participating in clinical trials, some from Re:Cognition Health’s UK centres, testing new-generation medications designed to slow down the progression of the disease. For those in the UK, you can still watch this on BBC iPlayer.

Watch on BBC iPlayer

1

Step 1

Quick pre-screening call with our patient engagement team to check which studies are suitable.
2

Step 2

Onsite screening consultation with our experienced doctors.
3

Step 3

If eligible, you will gain access to new medications or interventions, that have the potential to change lives.

About Clinical Trials

Clinical trials are essential for advancing our understanding of medicine and improving the healthcare and quality of life for everyone affected by dementia and cognitive impairment. In 2023 nearly a million people participated in health and social care research in the UK, according to the National Institute for Health and Care Research (NIHR)

This is a very exciting time for research, with every study conducted we understand more about specific diseases and conditions, getting closer to finding new treatments and ultimately a cure.

Types of Trials

According to the Alzheimer’s Society, over 1 million people in the UK will have a diagnosis of dementia by 2025. By 2051 this number will exceed 2 million. Worldwide it’s estimated that 82 million people will be suffering from dementia by 2030.

We are currently looking for volunteers to participate in these studies.

Learn More
Mild Cognitive Impairment affects between 5-20% of people aged 65 years and over in the UK. It is not a form of dementia, however, individuals with MCI often progress to developing dementia.

We are currently looking for volunteers to participate in these studies.

Learn More
Much research is underway in the field of Parkinson’s disease to determine why people develop this condition, as well as new treatments to help treat its symptoms. It is thought that Parkinson’s is caused by a combination of genetic and environmental factors.

We are currently looking for volunteers to participate in these studies.

Learn More
ADHD/ADD is not an illness, but a condition. This means it may predispose individuals to suffer medical and psychiatric conditions like depression, anxiety, conduct disorder, and alcohol and substance abuse. However, a diagnosis of ADHD doesn’t necessarily mean that individuals will have negative outcomes later in life.

Learn More
At present, there is no cure for Migraine. We’re working on a range of treatment options to change that. Migraines are unbelievably common in the UK, affecting up to 12 million people.

We are currently looking for volunteers to participate in these studies.

Learn More
We recognise that neurodiversity provides fantastic benefits, as evidenced by the numerous attributes and skills exhibited by individuals living very successful lives with autism.

We are currently looking for volunteers to participate in these studies.

Learn More
The currently approved disease-modifying therapies aren’t a cure for MS, but they can reduce how many relapses someone has and how serious they are. They can also slow down the damage caused by relapsing multiple sclerosis that builds up over time. The studies we conduct at Re:Cognition Health are also disease-modifying therapies however aiming to improve the efficacy (the success in slowing progression and/or symptoms) of current medications used.

We are currently looking for volunteers to participate in these studies.

Learn More

BENEFITS OF JOINING A TRIAL

Trials are FREE and voluntary
Volunteers have the opportunity to help develop new treatments for future generations
Study volunteers get early access to new treatments for memory loss and are monitored closely throughout the trial
Outstanding medical care is provided at no cost, participants get a rigourous health check including comprehensive health screens, MRI scans and PET scans. We ensure your GP is kept in the loop.
The chance to avoid lengthy NHS waiting lists and access specialist private healthcare
Travel expenses are reimbursed for each visit and complimentary refreshments are available

Clinical trials and new medications for Alzheimer's

Dr Emer MacSweeney, CEO and Founder of Re:Cognition Health talks about the new medications available for Alzheimer’s disease. We hear the stories of two clinical trial participants, Mike and David, and clinical trial partner, Cheryl, and how participating on a clinical trial for these new medications has helped them.

Our Clinics

Get ready for your visit

Our clinics located throughout the UK are set up for your comfort with experts and consultants to walk you through the trial process.

OUR UK AND USA CLINICS ARE PROUD TO BE PART OF THE PPD SELECT PARTNERSHIP PROGRAMME.

The Re:Cognition Health UK and US site networks are proud to be preferred sites within the PPD Select Partnership Program of Thermo Fisher Scientific’s PPD clinical research business, a global leader in clinical research.

We’re excited about the opportunities this relationship brings, and we are looking forward to working with the PPD Strategic Site Collaborations team and evolving our relationship within the PPD Select Program, across our existing ten sites.